Product price, shipping and contact information
Currently unavailable
Sorry, we can't display this right now.
Please contact us to place your order, or try again later.
Loading size & price…
Shipping and order information
Abpromise
Guaranteed product quality, expert customer support.
Find out more.
Overview
-
Product name
Anti-Collagen I antibody [COL-1]
See all Collagen I primary antibodies -
Description
Mouse monoclonal [COL-1] to Collagen I
-
Host species
Mouse
-
Tested applications
Suitable for: IHC-Fr, WBmore details
-
Species reactivity
Reacts with: Human
Predicted to work with: Rat, Cow, Pig, Deer -
Immunogen
Full length native protein (purified) corresponding to Cow Collagen I. Cow skin collagen type I
-
Epitope
The epitope recognized by the antibody may be sensitive to routine formalin fixation and paraffin embedding. There have been varying results when using this antibody in IHC-P. Please refer to our customer Abreviews for more protocol information and optimization steps when using this antibody in IHC-P.
-
Positive control
- WB: Natural Cow Collagen I protein (ab7526), IHC-Fr: Human tonsil tissue.
-
General notes
Production of this antibody has been changed on 23rd June 2016. The following lots are from ascites and are still in stock as of 23rd June 2016 : GR210978, GR175242, GR158374. Lot numbers higher than GR210978 will be from tissue culture supernatant. Please note that the dilutions may need to be adjusted accordingly.
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
Properties
-
Form
Liquid
-
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle.
-
Storage buffer
pH: 7.40
Preservative: 0.0976% Sodium azide
Constituent: PBS -
Concentration information loading...
-
Purity
Proprietary Purification
-
Purification notes
Purified from Tissue culture supernatant.
-
Clonality
Monoclonal
-
Clone number
COL-1
-
Isotype
IgG1
-
Research areas
- Cell Type Markers
- Tumor Associated
- Signal Transduction
- Cytoskeleton / ECM
- Extracellular Matrix
- ECM Proteins
- Collagen
- Stem Cells
- Mesenchymal Stem Cells
- Surface Molecules
- Stem Cells
- Mesenchymal Stem Cells
- Osteogenesis
- Cancer
- Tumor immunology
- Tumor-associated antigens
- Cancer
- Tumor biomarkers
- Tumor antigens
Associated products
-
Compatible Secondaries
-
Isotype control
- Mouse IgG1, kappa monoclonal [15-6E10A7] - Isotype Control (ab170190)
-
Positive Controls
- Native Cow Collagen I protein (ab7526)
- Native Human Collagen I protein (ab7533)
-
Recombinant Protein
- Recombinant Human Collagen I protein (ab158152)
-
Related Products
- Prestained Protein Ladder - Broad molecular weight (10 - 245 kDa) (ab116028)
- Mouse Pro-Collagen I alpha 1 ELISA Kit (ab210579)
- Human Pro-Collagen I alpha 1 ELISA Kit (ab210966)
- Mouse Pro-Collagen I alpha 1 Matched Antibody Pair Kit (ab216791)
- 10x Citrate Buffer pH 6.0 (ab64214)
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab6308 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
IHC-Fr | (2) | Use a concentration of 3.5 - 7 µg/ml. (amplification required).Use on unfixed tissue or acetone fixed tissue. |
WB | (2) | Use a concentration of 1 - 2 µg/ml. Use under non reducing condition. Detects a band of approximately 130 kDa (predicted molecular weight: 130 kDa). The antibody is reactive with the native (non-denaturing, helical) form of collagen type I and not reactive when tested on thermally denatured molecules. Use native (non-denaturing) conditions. Positive Control: Hu stomach, skin and adrenal gland tissue lysates. Acid or enzyme treatment with pepsin is a better method to isolate collagen. Continuous refrigeration throughout collagen extraction is important to avoid degradation and denaturation. Take care with pH, temperature, and concentration to avoid collagen polymerization. |
Notes |
---|
IHC-Fr (amplification required).Use on unfixed tissue or acetone fixed tissue. |
WB The antibody is reactive with the native (non-denaturing, helical) form of collagen type I and not reactive when tested on thermally denatured molecules. Use native (non-denaturing) conditions. Positive Control: Hu stomach, skin and adrenal gland tissue lysates. Acid or enzyme treatment with pepsin is a better method to isolate collagen. Continuous refrigeration throughout collagen extraction is important to avoid degradation and denaturation. Take care with pH, temperature, and concentration to avoid collagen polymerization. |
Target
-
Function
Type I collagen is a member of group I collagen (fibrillar forming collagen).
-
Tissue specificity
Forms the fibrils of tendon, ligaments and bones. In bones the fibrils are mineralized with calcium hydroxyapatite.
-
Involvement in disease
Defects in COL1A1 are the cause of Caffey disease (CAFFD) [MIM:114000]; also known as infantile cortical hyperostosis. Caffey disease is characterized by an infantile episode of massive subperiosteal new bone formation that typically involves the diaphyses of the long bones, mandible, and clavicles. The involved bones may also appear inflamed, with painful swelling and systemic fever often accompanying the illness. The bone changes usually begin before 5 months of age and resolve before 2 years of age.
Defects in COL1A1 are a cause of Ehlers-Danlos syndrome type 1 (EDS1) [MIM:130000]; also known as Ehlers-Danlos syndrome gravis. EDS is a connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. EDS1 is the severe form of classic Ehlers-Danlos syndrome.
Defects in COL1A1 are the cause of Ehlers-Danlos syndrome type 7A (EDS7A) [MIM:130060]; also known as autosomal dominant Ehlers-Danlos syndrome type VII. EDS is a connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. EDS7A is marked by bilateral congenital hip dislocation, hyperlaxity of the joints, and recurrent partial dislocations.
Defects in COL1A1 are a cause of osteogenesis imperfecta type 1 (OI1) [MIM:166200]. A dominantly inherited connective tissue disorder characterized by bone fragility and blue sclerae. Osteogenesis imperfecta type 1 is non-deforming with normal height or mild short stature, and no dentinogenesis imperfecta.
Defects in COL1A1 are a cause of osteogenesis imperfecta type 2A (OI2A) [MIM:166210]; also known as osteogenesis imperfecta congenita. A connective tissue disorder characterized by bone fragility, with many perinatal fractures, severe bowing of long bones, undermineralization, and death in the perinatal period due to respiratory insufficiency.
Defects in COL1A1 are a cause of osteogenesis imperfecta type 3 (OI3) [MIM:259420]. A connective tissue disorder characterized by progressively deforming bones, very short stature, a triangular face, severe scoliosis, grayish sclera, and dentinogenesis imperfecta.
Defects in COL1A1 are a cause of osteogenesis imperfecta type 4 (OI4) [MIM:166220]; also known as osteogenesis imperfecta with normal sclerae. A connective tissue disorder characterized by moderately short stature, mild to moderate scoliosis, grayish or white sclera and dentinogenesis imperfecta.
Genetic variations in COL1A1 are a cause of susceptibility to osteoporosis (OSTEOP) [MIM:166710]; also known as involutional or senile osteoporosis or postmenopausal osteoporosis. Osteoporosis is characterized by reduced bone mass, disruption of bone microarchitecture without alteration in the composition of bone. Osteoporotic bones are more at risk of fracture.
Note=A chromosomal aberration involving COL1A1 is found in dermatofibrosarcoma protuberans. Translocation t(17;22)(q22;q13) with PDGF. -
Sequence similarities
Belongs to the fibrillar collagen family.
Contains 1 fibrillar collagen NC1 domain.
Contains 1 VWFC domain. -
Post-translational
modificationsProline residues at the third position of the tripeptide repeating unit (G-X-Y) are hydroxylated in some or all of the chains. Proline residues at the second position of the tripeptide repeating unit (G-X-Y) are hydroxylated in some of the chains.
O-linked glycan consists of a Glc-Gal disaccharide bound to the oxygen atom of a post-translationally added hydroxyl group. -
Cellular localization
Secreted > extracellular space > extracellular matrix.
- Information by UniProt
-
Database links
- Entrez Gene: 282187 Cow
- Entrez Gene: 282188 Cow
- Entrez Gene: 1277 Human
- Entrez Gene: 1278 Human
- Entrez Gene: 29393 Rat
- Entrez Gene: 84352 Rat
- Omim: 120150 Human
- Omim: 120160 Human
see all
-
Alternative names
- Alpha 1 type I collagen antibody
- Alpha 2 type I collagen antibody
- alpha 2 type I procollagen antibody
see all
Images
-
Immunohistochemistry (Frozen sections) - Anti-Collagen I antibody [COL-1] (ab6308)This image was kindly supplied as part of the review submitted by Arvi-Matti Kuusniemi
Immunoperoxidase staining of unfixed frozen tissue sections with ab6308. Picture of human kidney cortex showing two glomeruli and surrounding tubulointerstitium.
-
Western blot - Anti-Collagen I antibody [COL-1] (ab6308)
Lane 1 : Anti-Collagen I antibody [COL-1] (ab6308) at 2 µg/ml
Lane 2 : Anti-Collagen I antibody [COL-1] (ab6308) at 1 µg/ml
Lane 3 : Anti-Collagen I antibody [COL-1] (ab6308) at 0.5 µg/ml
Lane 4 : Anti-Collagen I antibody [COL-1] (ab6308) at 0 µg/mlAll lanes : Recombinant human Collagen 1
Predicted band size: 130 kDa
-
Western blot - Anti-Collagen I antibody [COL-1] (ab6308)This image is courtesy of an anonymous Abreview
Anti-Collagen I antibody [COL-1] (ab6308) at 1/1000 dilution + Human brain whole tissue lysate at 10 µg
Secondary
An HRP-conjugated goat polyclonal to mouse IgG at 1/7500 dilutionDeveloped using the ECL technique.
Performed under reducing conditions.
Predicted band size: 130 kDa
Exposure time: 24 hours
See Abreview
-
Immunohistochemistry (Frozen sections) - Anti-Collagen I antibody [COL-1] (ab6308)
Acetone-fixed human tonsil tissue frozen section stained for Collagen I with ab6308 at 7 μg/mL in immunohistochemical analysis.
Protocols
- Immunohistochemistry protocols
- Immunocytochemistry & immunofluorescence protocols
- Western blot protocols
Click here to view the general protocols
Datasheets and documents
-
SDS download
-
Datasheet download
Download
References (464)
Publishing research using ab6308? Please let us know so that we can cite the reference in this datasheet.
ab6308 has been referenced in 464 publications.
- Pappalardo A et al. Engineering edgeless human skin with enhanced biomechanical properties. Sci Adv 9:eade2514 (2023). PubMed: 36706190
- Cicione C et al. Micro-fragmented and nanofat adipose tissue derivatives: In vitro qualitative and quantitative analysis. Front Bioeng Biotechnol 11:911600 (2023). PubMed: 36733959
- Xie W et al. Herpud1 deficiency alleviates hom*ocysteine-induced aortic valve calcification. Cell Biol Toxicol 39:2665-2684 (2023). PubMed: 36746840
- Du L et al. Single cell and lineage tracing studies reveal the impact of CD34+ cells on myocardial fibrosis during heart failure. Stem Cell Res Ther 14:33 (2023). PubMed: 36805782
- Carvalho VHC et al. Long-term exercise preserves pancreatic islet structure and β-cell mass through attenuation of islet inflammation and fibrosis. FASEB J 37:e22822 (2023). PubMed: 36809666
View all Publications for this product